Ilona Fazekas

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Locomotion and proliferation of glioblastoma cells in vitro: statistical evaluation of videomicroscopic observations

Balás Hegedüs, András Czirók, Ilona Fazekas et al. · Journal of neurosurgery · 2000 · 62 citations

The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymia

Erika Szádóczky, Ilona Fazekas, Zoltán Rihmer et al. · Journal of Affective Disorders · 1994 · 34 citations

Psychological Co-morbidities, Psychiatry, Early-late-onset Dysthymia +14

Intrasellar hamartoma associated with pituitary adenoma

F. Slowik, Ilona Fazekas, K. B�lint et al. · Acta Neuropathologica · 1990 · 25 citations

Pituitary Gland, Intrasellar Hamartoma, Surgical Pathology +3